A.Reinisch: Modeling human clonal hematopoiesis and leukemogenesis using genome engineering tools


Dear colleagues and friends, 

We would like to invite you to a seminar by Andreas Reinisch (Universität Graz): Modeling human clonal hematopoiesis and leukemogenesis using genome engineering tools. 

Tuesday, 29.07.2025 | 16:00 TranslaTUM Auditorium, Einsteinstraße 25, 81675 München. 

Andreas Reinisch is physician scientist specializing in biology of stem cell disorders. He is assistant professor in the Department of Hematology and Transfusion Medicine at the University of Graz.

Andreas research focuses on unraveling mechanisms governing the trajectory from clonal hematopoiesis to myeloid neoplasms using humanized mouse models. Andreas completed his PostDoc at the Stanford School of Medicine in the prestigious lab of Ravi Majeti, where he performed genetic engineering on human hematopoietic stem cells to express gain of function oncogenic mutations including those found in clonal hematopoiesis such as TET2, as well as generating humanized in vivo bone marrow models to examine mechanisms of leukemogenesis.

If you would like to meet Andreas, please contact Katharina (katharina.goetze@tum.de).

We are looking forward to welcoming you to the talk!



Klinik und Poliklinik für Innere Medizin III

TUM School of Medicine and Health

Ismaningerstr. 22
81675 München

 keywords: targeted therapy, haematology

Datum

29.07.2025

Uhrzeit

16:00 - 17:00

Ort

TranslaTUM Auditorium TUM Klinikum Rechts der Isar Einsteinstrasse 25; 81675 München

Veranstalter

Klinik und Poliklinik für Innere Medizin III; TUM School of Medicine and Health 

Anmeldung unter


iCal-Download